Cargando…
Trypanosoma cruzi Mitochondrial Peroxiredoxin Promotes Infectivity in Macrophages and Attenuates Nifurtimox Toxicity
Trypanosoma cruzi is the causative agent of Chagas disease which is currently treated by nifurtimox (NFX) and benznidazole (BZ). Nevertheless, the mechanism of action of NFX is not completely established. Herein, we show the protective effects of T. cruzi mitochondrial peroxiredoxin (MPX) in macroph...
Autores principales: | Specker, Gabriela, Estrada, Damián, Radi, Rafael, Piacenza, Lucía |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855072/ https://www.ncbi.nlm.nih.gov/pubmed/35186785 http://dx.doi.org/10.3389/fcimb.2022.749476 |
Ejemplares similares
-
Structural New Data for Mitochondrial Peroxiredoxin From Trypanosoma cruzi Show High Similarity With Human Peroxiredoxin 3: Repositioning Thiostrepton as Antichagasic Drug
por: Rivera-Santiago, Lucio, et al.
Publicado: (2022) -
Detection of Trypanosoma cruzi by PCR in adults with chronic Chagas disease treated with nifurtimox
por: Vergara, Camilo, et al.
Publicado: (2019) -
The Complete Mitochondrial DNA of Trypanosoma cruzi: Maxicircles and Minicircles
por: Callejas-Hernández, Francisco, et al.
Publicado: (2021) -
An Evolutionary View of Trypanosoma Cruzi Telomeres
por: Ramirez, Jose Luis
Publicado: (2020) -
N(OX)2-derived superoxide radical is crucial to control acute Trypanosoma cruzi infection
por: Prolo, Carolina, et al.
Publicado: (2021)